2-178790082-T-C

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_001267550.2(TTN):​c.1834A>G​(p.Lys612Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000384 in 1,612,992 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.000053 ( 0 hom., cov: 32)
Exomes š‘“: 0.000037 ( 0 hom. )

Consequence

TTN
NM_001267550.2 missense

Scores

1
4
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 1.87

Publications

3 publications found
Variant links:
Genes affected
TTN (HGNC:12403): (titin) This gene encodes a large abundant protein of striated muscle. The product of this gene is divided into two regions, a N-terminal I-band and a C-terminal A-band. The I-band, which is the elastic part of the molecule, contains two regions of tandem immunoglobulin domains on either side of a PEVK region that is rich in proline, glutamate, valine and lysine. The A-band, which is thought to act as a protein-ruler, contains a mixture of immunoglobulin and fibronectin repeats, and possesses kinase activity. An N-terminal Z-disc region and a C-terminal M-line region bind to the Z-line and M-line of the sarcomere, respectively, so that a single titin molecule spans half the length of a sarcomere. Titin also contains binding sites for muscle associated proteins so it serves as an adhesion template for the assembly of contractile machinery in muscle cells. It has also been identified as a structural protein for chromosomes. Alternative splicing of this gene results in multiple transcript variants. Considerable variability exists in the I-band, the M-line and the Z-disc regions of titin. Variability in the I-band region contributes to the differences in elasticity of different titin isoforms and, therefore, to the differences in elasticity of different muscle types. Mutations in this gene are associated with familial hypertrophic cardiomyopathy 9, and autoantibodies to titin are produced in patients with the autoimmune disease scleroderma. [provided by RefSeq, Feb 2012]
TTN Gene-Disease associations (from GenCC):
  • dilated cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • dilated cardiomyopathy 1G
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • early-onset myopathy with fatal cardiomyopathy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • TTN-related myopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • myopathy, myofibrillar, 9, with early respiratory failure
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, Ambry Genetics
  • tibial muscular dystrophy
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
  • autosomal recessive limb-girdle muscular dystrophy type 2J
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • hypertrophic cardiomyopathy 9
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • congenital myopathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary skeletal muscle disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.032369256).
BP6
Variant 2-178790082-T-C is Benign according to our data. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976. Variant chr2-178790082-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 179976.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTNNM_001267550.2 linkc.1834A>G p.Lys612Glu missense_variant Exon 12 of 363 ENST00000589042.5 NP_001254479.2 A0A0A0MTS7
TTNNM_133379.5 linkc.1834A>G p.Lys612Glu missense_variant Exon 12 of 46 ENST00000360870.10 NP_596870.2 Q8WZ42-6Q7Z3B7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTNENST00000589042.5 linkc.1834A>G p.Lys612Glu missense_variant Exon 12 of 363 5 NM_001267550.2 ENSP00000467141.1 A0A0A0MTS7
TTNENST00000360870.10 linkc.1834A>G p.Lys612Glu missense_variant Exon 12 of 46 5 NM_133379.5 ENSP00000354117.4 Q8WZ42-6

Frequencies

GnomAD3 genomes
AF:
0.0000526
AC:
8
AN:
152194
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.0000916
AC:
23
AN:
251028
AF XY:
0.0000737
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00208
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000370
AC:
54
AN:
1460798
Hom.:
0
Cov.:
31
AF XY:
0.0000399
AC XY:
29
AN XY:
726740
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33446
American (AMR)
AF:
0.00
AC:
0
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.00165
AC:
43
AN:
26090
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39510
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86234
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53314
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5760
European-Non Finnish (NFE)
AF:
0.00000540
AC:
6
AN:
1111390
Other (OTH)
AF:
0.0000663
AC:
4
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000526
AC:
8
AN:
152194
Hom.:
0
Cov.:
32
AF XY:
0.0000538
AC XY:
4
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41458
American (AMR)
AF:
0.00
AC:
0
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68018
Other (OTH)
AF:
0.000478
AC:
1
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000204
Hom.:
0
Bravo
AF:
0.0000378
ExAC
AF:
0.0000577
AC:
7
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Jan 02, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Aug 27, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The Lys612Glu variant in TTN has not been previously reported in individuals wit h cardiomyopathy and was absent from large population studies. Computational pre diction tools and conservation analysis suggest this variant may not impact the protein, though this information is not predictive enough to rule out pathogenic ity. In summary, the clinical significance of the Lys612Glu variant is uncertain . -

Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Oct 25, 2023
Revvity Omics, Revvity
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.46
BayesDel_addAF
Benign
-0.048
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
23
DANN
Benign
0.97
Eigen
Benign
0.15
Eigen_PC
Uncertain
0.24
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.78
T;T;T;.;T;T;T;T
M_CAP
Benign
0.037
D
MetaRNN
Benign
0.032
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.88
T
PhyloP100
1.9
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-2.1
N;N;.;.;N;N;.;N
REVEL
Benign
0.14
Sift
Pathogenic
0.0
D;D;.;.;D;D;.;D
Sift4G
Benign
0.11
.;.;.;.;.;.;.;T
Polyphen
0.26, 0.91
.;.;.;B;.;.;B;P
Vest4
0.30
MVP
0.20
MPC
0.18
ClinPred
0.17
T
GERP RS
4.7
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs727505256; hg19: chr2-179654809; COSMIC: COSV60111066; API